Curcumin compounds and total microorganisms in turmeric kombucha as a potential therapy in rats obesity model

Zulfia Rosyidatun Nisa'; Sinu Andhi Jusuf; Ratih Dewi Yudhani

doi:10.21927/ijnd.2025.13(2).114-124

Curcumin compounds and total microorganisms in turmeric kombucha as a potential therapy in rats obesity model

Zulfia Rosyidatun Nisa', Sinu Andhi Jusuf, Ratih Dewi Yudhani

Abstract

ABSTRAK

Latar belakang: Prevalensi obesitas meningkat signifikan dalam satu dekade terakhir dan berisiko menimbulkan berbagai komplikasi seperti diabetes melitus tipe 2, kardiovaskular, bahkan kanker. Terapi farmakologi obesitas seperti liraglutide dan orlistat dapat memberikan efek negatif pada tubuh seperti gangguan saluran pencernaan. Hal ini mendorong pengembangan terapi berbahan alami untuk obesitas. Kombucha dan kunyit kuning secara tunggal dilaporkan bersifat antioksidan dan mampu memperbaiki obesitas. Kombinasi kombucha kunyit kuning berpotensi dikembangkan sebagai minuman probiotik untuk obesitas karena senyawa bioaktif yang dikandungnya. Namun, eksplorasi fitokimia dan mikroorganisme pada turmeric kombucha masih sangat terbatas dan penelitian kombinasi kombucha kunyit kuning untuk obesitas belum pernah dilakukan sebelumnya.

Tujuan: Mengeksplorasi kandungan fitokimia dan total mikroorganisme kombucha kunyit kuning dan kemampuannya untuk memperbaiki obesitas.

Metode: Eksperimental laboratorik dengan rancangan pre-post control group dan deskriptif observasional. Analisis kurkumin menggunakan KLT Densitometri. Mikroorganisme dianalisis dengan metode pour plate kemudian dihitung berdasarkan total plate count. Tikus model obesitas diberikan tiga variasi dosis kombucha kunyit kuning selama 28 hari dan dilakukan penilaian perubahan indeks Lee yang diuji statistik menggunakan Kruskal Wallis (p<0.05) dan Post hoc Dunn Test.

Hasil: Hasil penelitian menunjukkan kandungan kurkumin pada kombucha kunyit kuning sebesar 0,73 mg/L dan total mikroorganisme sebesar 2,60 x 10⁷ CFU/ml. Kombucha kunyit kuning memperbaiki indeks Lee tikus model obesitas dibanding kontrol negatif (p<0.05) dengan dosis paling efektif sebesar 4,4 ml/200 g/hari (dosis tertinggi di penelitian ini).

Kesimpulan: Kombucha kunyit kuning memiliki kandungan kurkumin dan manfaat mikoorganisme yang dapat memperbaiki indeks Lee pada tikus model obesitas.

Kata Kunci: kombucha kunyit kuning; kurkumin; mikroorganisme; obesitas

ABSTRACT

Background: The prevalence of obesity has increased significantly in the last decade, raising the risk of complications such as type 2 diabetes, cardiovascular diseases, and even cancer. Pharmacological therapies for obesity, such as liraglutide and orlistat, can have negative effects on the body, including gastrointestinal disorders. This drives interest in the development of natural-based therapies for obesity. Kombucha and turmeric individually are known for their antioxidant properties and their ability to address obesity. The combination of turmeric kombucha has the potential to be developed as a probiotic drink for obesity due to the bioactive compounds it contains. However, research into the phytochemical profile and microorganisms in turmeric kombucha is still limited, and no studies have been conducted on the combination of turmeric kombucha for obesity treatment.

Objectives: To explore the phytochemical content and total microorganisms in turmeric kombucha and to evaluate its potential in improving obesity treatment.

Methods: Laboratory experiments were conducted with pre-post control group design and descriptive observational analysis. Curcumin levels were analysed using KLT Densitometry, while microorganisms were identified through the pour plate method and quantified via total plate count. Obese model rats received three different doses of turmeric kombucha over 28 days, and changes in their Lee index value were assessed and statistically analysed using Kruskal Wallis (p<0.05) and Post hoc Dunn Test.

Results: The findings revealed that the curcumin concentration in turmeric kombucha was 0.73 mg/L and the total microorganisms were 2,60 x 107 CFU/ml. Kombucha yellow turmeric improved the Lee index of obese model rat compared to negative control (p<0.05) with the most effective dose being 4.4 ml/200 g/day (the highest dose in this study).

Conclusions: Turmeric kombucha contains curcumin and beneficial microorganisms, which can improve the Lee index in obese model rats.

Keywords: curcumin; obesity; microorganisms; turmeric kombucha

Received: 17 Jan 2025; Revised: 20 Sep 2024; Accepted: 26 Jan 2025; Available online: 30 Mar 2025; Published: 30 Mar 2025

Keywords

kombucha kunyit kuning; kurkumin; mikroorganisme; obesitas; curcumin; obesity; microorganisms; turmeric kombucha

Full Text:

PDF

References

Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol (Lausanne). 2021;12(September):1–9.

World Health Organization. Obesity and Overweight [Internet]. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

Kemenkes. Survey Kesehatan Indonesia. Kota Kediri Dalam Angka. 2023.

Sperrin M, Marshall AD, Higgins V, Renehan AG, Buchan IE. Body mass index relates weight to height differently in women and older adults: Serial cross-sectional surveys in England (1992-2011). J Public Heal (United Kingdom). 2016;38(3):607–13.

Seo YG, Lim H, Kim Y, Ju YS, Lee HJ, Jang HB, et al. The effect of a multidisciplinary lifestyle intervention on obesity status, body composition, physical fitness, and cardiometabolic risk markers in children and adolescents with obesity. Nutrients. 2019;11(1):1–16.

Ghaffari A, Rafraf M, Navekar R, Sepehri B, Asghari-Jafarabadi M, Ghavami SM. Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD). Int J Vitam Nutr Res. 2019;89(5–6):293–302.

Yudhani RD, Sari Y, Nugrahaningsih DAA, Sholikhah EN, Rochmanti M, Purba AKR, et al. In Vitro Insulin Resistance Model: A Recent Update. J Obes. 2023;2023.

Tchang Beverly, Aras Mohini, Rekha B Kumar, Louis J. Aronne M. Pharmacologic Treatment of Overweight and Obesity in Adults [Internet]. 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279038/

Othman ZA, Zakaria Z, Suleiman JB, Ghazali WSW, Mohamed M. Anti-atherogenic effects of orlistat on obesity-induced vascular oxidative stress rat model. Antioxidants. 2021;10(2):1–16.

de Miranda JF, Ruiz LF, Silva CB, Uekane TM, Silva KA, Gonzalez AGM, et al. Kombucha: A review of substrates, regulations, composition, and biological properties. J Food Sci. 2022;87(2):503–27.

Júnior JC da S, Meireles Mafaldo Í, de Lima Brito I, Tribuzy de Magalhães Cordeiro AM. Kombucha: Formulation, chemical composition, and therapeutic potentialities. Curr Res Food Sci. 2022;5(February):360–5.

Costa MA de C, Vilela DL de S, Fraiz GM, Lopes IL, Coelho AIM, Castro LCV, et al. Effect of kombucha intake on the gut microbiota and obesity-related comorbidities: A systematic review. Crit Rev Food Sci Nutr [Internet]. 2021;63(19):3851–66. Available from: https://doi.org/10.1080/10408398.2021.1995321

Jakubczyk K, Kałduńska J, Kochman J, Janda K. Chemical profile and antioxidant activity of the kombucha beverage derived from white, green, black and red tea. Antioxidants. 2020;9(5).

DuMez-Kornegay RN, Baker LS, Morris AJ, DeLoach WLM, Dowen RH. Kombucha Tea-associated microbes remodel host metabolic pathways to suppress lipid accumulation [Internet]. Vol. 20, PLoS Genetics. 2024. Available from: http://dx.doi.org/10.1371/journal.pgen.1011003

Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism [Internet]. 2019;92:6–10. Available from: https://doi.org/10.1016/j.metabol.2018.09.005

Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7):s176–85.

Moreira G V., Araujo LCC, Murata GM, Matos SL, Carvalho CRO. Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice. Biomed Pharmacother [Internet]. 2022;155(September):113660. Available from: https://doi.org/10.1016/j.biopha.2022.113660

Permatasari HK, Firani NK, Prijadi B, Irnandi DF, Riawan W, Yusuf M, et al. Kombucha drink enriched with sea grapes (Caulerpa racemosa) as potential functional beverage to contrast obesity: An in vivo and in vitro approach. Clin Nutr ESPEN [Internet]. 2022;49:232–40. Available from: https://doi.org/10.1016/j.clnesp.2022.04.015

Zubaidah E, Afgani CA, Kalsum U, Srianta I, Blanc PJ. Comparison of in vivo antidiabetes activity of snake fruit Kombucha, black tea Kombucha and metformin. Biocatal Agric Biotechnol [Internet]. 2019;17(November 2018):465–9. Available from: https://doi.org/10.1016/j.bcab.2018.12.026

Permatasari HK, Nurkolis F, Gunawan W Ben, Yusuf VM, Yusuf M, Kusuma RJ, et al. Modulation of gut microbiota and markers of metabolic syndrome in mice on cholesterol and fat enriched diet by butterfly pea flower kombucha. Curr Res Food Sci [Internet]. 2022;5(August):1251–65. Available from: https://doi.org/10.1016/j.crfs.2022.08.005.

Tim Badan Pusat Statistik. Statistik Tanaman Biofarmaka Tahun 2018. Jakarta.

Databoks. Volume Produksi Kunyit Indonesia (2019-2023) [Internet]. 2024. Available from: https://databoks.katadata.co.id/datapublish/2024/06/12/produksi-kunyit-naik-pada-2023-tertinggi-dalam-5-tahun

Fu YS, Chen TH, Weng L, Huang L, Lai D, Weng CF. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential. Biomed Pharmacother [Internet]. 2021;141(April):111888. Available from: https://doi.org/10.1016/j.biopha.2021.111888

Hassan MH, Awadalla EA, Abd El-Kader AEKM, Seifeldin EA, Mahmoud MA, Muddathir ARM, et al. Antitoxic Effects of Curcumin against Obesity-Induced Multi-Organs’ Biochemical and Histopathological Abnormalities in an Animal Model. Evidence-based Complement Altern Med. 2022;2022.

Khazi, Mahammed Ilyas; Liaqat, Fakhra; Yan, Yilin; Zhu D. Fermentation, Functional analysis, and biological activities of turmeric kombucha. sci food agric. 2024;104(2):759–68.

Tabanelli R, Brogi S, Calderone V. Improving curcumin bioavailability: Current strategies and future perspectives. Pharmaceutics. 2021;13(10).

Cohen BJ, Professor of Physiology A, Clarkson TB, Professor of Experi-mental Medicine A, Rabstein MM, Soave OA, et al. Guide for Laboratory Animal Facilities and Care. ILAR J [Internet]. 2021;62(3):345–58. Available from: https://doi.org/10.1093/ilar/ilac012

Sundari I, Indarto D, Dirgahayu P. Dual Extracts of Star Fruit Leaves and Toddalia accuelata Leaves as Antiobesity in Rats. J Aisyah J Ilmu Kesehat. 2022;7(1):93–100.

Innayah N, Azam M, Yuniastuti A. The Effect of Monosodium Glutamate on The Lee Index in Mice (Mus Musculus). Public Heal Perspect J [Internet]. 2021;6(2):2021–165. https://journal.unnes.ac.id/nju/index.php/phpj/article/view/27968

Hohnadel M, Maumy M, Chollet R. Development of a micromanipulation method for single cell isolation of prokaryotes and its application in food safety. PLoS One. 2018;13(5):1–14.

Mas P, Tran T, Verdier F, Martin A, Alexandre H, Grandvalet C, et al. Evolution in Composition of Kombucha Consortia over Three Consecutive Years in Production Context. Foods. 2022;11(4):1–13.

Terrones-Fernandez I, Casino P, López A, Peiró S, Ríos S, Nardi-Ricart A, et al. Improvement of the Pour Plate Method by Separate Sterilization of Agar and Other Medium Components and Reduction of the Agar Concentration. Microbiol Spectr. 2023;11(1).

Wahyuni DSC, Artanti AN, Rinanto Y. Quantitative analysis of Curcuminoid collected from different location in Indonesia by TLC-Densitometry and its antioxidant capacity. IOP Conf Ser Mater Sci Eng. 2018;349(1).

Pyka-Pająk A, Dołowy M, Parys W, Bober K, Janikowska G. A simple and cost-effective TLC-densitometric method for the quantitative determination of acetylsalicylic acid and ascorbic acid in combined effervescent tablets. Molecules. 2018;23(12):1–17.

Zubaidah E, Charista Dea E, Rahayu AP, Fibrianto K, Saparianti E, Sujuti H, et al. Enhancing immunomodulatory properties of Javanese turmeric (Curcuma xanthorrhiza) kombucha against diethylnitrosamine in male Balb/c mice. Process Biochem [Internet]. 2023;133(August):303–8. Available from: https://doi.org/10.1016/j.procbio.2023.09.012

Zubaidah E, Nisak YK, Susanti I, Widyaningsih TD, Srianta I, Tewfik I. Turmeric Kombucha as effective immunomodulator in Salmonella typhi-infected experimental animals. Biocatal Agric Biotechnol [Internet]. 2021;37(September):102181. https://doi.org/10.1016/j.bcab.2021.102181

Xu S, Wang Y, Wang J, Geng W. Kombucha Reduces Hyperglycemia in Type 2 Diabetes of Mice by Regulating Gut Microbiota and ItXu, S., Wang, Y., Wang, J., and Geng, W., 2022. Kombucha Reduces Hyperglycemia in Type 2 Diabetes of Mice by Regulating Gut Microbiota and Its Metabolites. Foods,. Foods. 2022;11(5).

Kenné Toussé R, Dangang Bossi DS, Dandji Saah MB, Foko Kouam EM, Njapndounke B, Tambo Tene S, et al. Effect of Curcuma longa Rhizome Powder on Metabolic Parameters and Oxidative Stress Markers in High-Fructose and High-Fat Diet-Fed Rats. J Food Biochem. 2024;2024.

Urrutia MAD, Ramos AG, Menegusso RB, Lenz RD, Ramos MG, Tarone AG, et al. Effects of supplementation with kombucha and green banana flour on Wistar rats fed with a cafeteria diet. Heliyon. 2021;7(5).

Behrouz V, Jazayeri S, Aryaeian N, Zahedi MJ, Hosseini F. Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Middle East J Dig Dis [Internet]. 2017;9(3):151–9. http://dx.doi.org/10.15171/mejdd.2017.66

Michael DR, Jack AA, Masetti G, Davies TS, Loxley KE, Kerry-Smith J, et al. A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being. Sci Rep. 2020;10(1):1–12.

Nosrati-Oskouie M, Aghili-Moghaddam NS, Sathyapalan T, Sahebkar A. Impact of curcumin on fatty acid metabolism. Phyther Res. 2021;35(9):4748–62.

Unhapipatpong C, Polruang N, Shantavasinkul PC, Julanon N, Numthavaj P, Thakkinstian A. The effect of curcumin supplementation on weight loss and anthropometric indices: an umbrella review and updated meta-analyses of randomized controlled trials. Am J Clin Nutr [Internet]. 2023;117(5):1005–16. Available from: https://doi.org/10.1016/j.ajcnut.2023.03.006

Dieterich W, Schink M, Zopf Y . Microbiota in the Gastrointestinal Tract. Med Sci (Basel, Switzerland). 2018;6(4):1–15.

Breton J, Galmiche M, Déchelotte P. Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics. Microorganisms. 2022;10(2).

Anand S, Mande SS. Diet, microbiota and gut-lung connection. Front Microbiol. 2018;9(SEP).

Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbial dysbiosis-induced obesity: Role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020;123(10):1127–37.

Stiemsma LT, Nakamura RE, Nguyen JG, Michels KB. Does Consumption of Fermented Foods Modify the Human Gut Microbiota? J Nutr [Internet]. 2020;150(7):1680–92. https://www.sciencedirect.com/science/article/pii/S0022316622022210

Kong D, Zhang Z, Chen L, Huang W, Zhang F, Wang L, et al. Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy. Redox Biol [Internet]. 2020;36(April):101600. https://doi.org/10.1016/j.redox.2020.101600

Asadi A, Shadab Mehr N, Mohamadi MH, Shokri F, Heidary M, Sadeghifard N, et al. Obesity and gut–microbiota–brain axis: A narrative review. J Clin Lab Anal. 2022;36(5):1–11.

Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, et al. Leptin and Obesity: Role and Clinical Implication. Front Endocrinol (Lausanne). 2021;12(May):1–14.

Gabriel FC, Fantuzzi G. The association of short-chain fatty acids and leptin metabolism: a systematic review. Nutr Res [Internet]. 2019;72:18–35. Available from: https://doi.org/10.1016/j.nutres.2019.08.006

Akbari M, Lankarani KB, Tabrizi R, Ghayour-Mobarhan M, Peymani P, Ferns G, et al. The effects of curcumin on weight loss among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2019;10(JUN):1–13.

DOI: http://dx.doi.org/10.21927/ijnd.2025.13(2).114-124